{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-008984","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2025-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.754471+00:00","generated_at":"2026-05-18T12:47:30.139203+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Aclaris Therapeutics posts updated corporate presentation; no material changes discernible","bullets":["Presentation includes corporate strategy and pipeline overview; no financial results or guidance changes disclosed.","No other material events or financial updates reported in the 8-K filing.","The presentation is available on the company's investor relations website."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-008984","json":"https://secwatch.observer/filing/0001558370-25-008984.json","markdown":"https://secwatch.observer/filing/0001558370-25-008984.md","text":"https://secwatch.observer/filing/0001558370-25-008984.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000155837025008984/0001558370-25-008984-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000155837025008984/acrs-20250630x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:47:30.139203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}